Home > Insider Trading > Filing (0001654954-17-011663)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1672645	Myron Kaplan	C/O Kleinberg, Kaplan, Wolff &Amp; Cohen, Pc 551 Fifth Avenue, 18Th Floor New York NY 10176		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-12	104,166	$0.48	284,166	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$2.24	2027-02-21	40,000	40,000	Direct
Common Stock	Restricted Stock Units	$0.00		10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$4.28	2026-04-28	50,000	50,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-02-21	40,000	40,000	Direct
	10,000	10,000	Direct
2026-04-28	50,000	50,000	Direct

Footnotes

Purchase was contracted on November 17, 2017, but not closed until December 12, 2017.
These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
These options were granted on 4/28/2016. These options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.